JP2015519322A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519322A5
JP2015519322A5 JP2015509395A JP2015509395A JP2015519322A5 JP 2015519322 A5 JP2015519322 A5 JP 2015519322A5 JP 2015509395 A JP2015509395 A JP 2015509395A JP 2015509395 A JP2015509395 A JP 2015509395A JP 2015519322 A5 JP2015519322 A5 JP 2015519322A5
Authority
JP
Japan
Prior art keywords
alkyl
group
groups
cycloalkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015509395A
Other languages
English (en)
Japanese (ja)
Other versions
JP6236702B2 (ja
JP2015519322A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/058840 external-priority patent/WO2013164292A1/en
Publication of JP2015519322A publication Critical patent/JP2015519322A/ja
Publication of JP2015519322A5 publication Critical patent/JP2015519322A5/ja
Application granted granted Critical
Publication of JP6236702B2 publication Critical patent/JP6236702B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015509395A 2012-04-30 2013-04-29 インダニルオキシジヒドロベンゾフラニル酢酸 Active JP6236702B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12166095 2012-04-30
EP12166095.5 2012-04-30
PCT/EP2013/058840 WO2013164292A1 (en) 2012-04-30 2013-04-29 Indanyloxydihydrobenzofuranylacetic acids

Publications (3)

Publication Number Publication Date
JP2015519322A JP2015519322A (ja) 2015-07-09
JP2015519322A5 true JP2015519322A5 (enExample) 2016-06-23
JP6236702B2 JP6236702B2 (ja) 2017-11-29

Family

ID=48325664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015509395A Active JP6236702B2 (ja) 2012-04-30 2013-04-29 インダニルオキシジヒドロベンゾフラニル酢酸

Country Status (7)

Country Link
US (1) US8809376B2 (enExample)
EP (1) EP2844653B1 (enExample)
JP (1) JP6236702B2 (enExample)
AR (1) AR090879A1 (enExample)
TW (1) TW201406739A (enExample)
UY (1) UY34773A (enExample)
WO (1) WO2013164292A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2953681B1 (en) * 2013-02-06 2017-03-15 Boehringer Ingelheim International GmbH New indanyloxydihydrobenzofuranylacetic acids
CA2928097A1 (en) 2013-11-14 2015-07-02 Cadila Healthcare Limited Novel heterocyclic compounds
SI3752501T1 (sl) 2018-02-13 2023-08-31 Gilead Sciences, Inc. Inhibitorji pd-1/pd-l1
CA3093130C (en) 2018-04-19 2023-10-17 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
SI3820572T1 (sl) 2018-07-13 2023-12-29 Gilead Sciences, Inc. Inhibitorji pd-1/pd-l1
JP7158577B2 (ja) 2018-10-24 2022-10-21 ギリアード サイエンシーズ, インコーポレイテッド Pd-1/pd-l1阻害剤
CN110372651A (zh) * 2019-07-22 2019-10-25 上海师范大学 一种含苯并呋喃骨架的茚衍生物的合成方法
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
AU2021275038A1 (en) 2020-05-19 2022-12-22 Kallyope, Inc. AMPK activators
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4594611B2 (ja) * 2002-11-08 2010-12-08 武田薬品工業株式会社 受容体機能調節剤
US7960369B2 (en) 2002-11-08 2011-06-14 Takeda Pharmaceutical Company Limited Receptor function regulator
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
CA2527691C (en) 2003-05-30 2013-01-22 Takeda Pharmaceutical Company Limited Condensed ring compound
CA2621949A1 (en) 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
EP2006271A4 (en) 2006-03-30 2011-08-10 Asahi Kasei Pharma Corp SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF
CL2007001873A1 (es) * 2006-06-27 2008-01-04 Takeda Pharmaceutical Acido((3s))-6-((¨2,6-dimetil-4-(3-(metilsulfonil)-propoxi)bifenil-3-il)metoxi-2,3-dihidro-1-benzofuran-3-il)acetico o una sal del mismo
CA2727340A1 (en) 2008-06-25 2009-12-30 Daiichi Sankyo Company, Limited Carboxylic acid compound
JP5551707B2 (ja) 2008-10-15 2014-07-16 アムジエン・インコーポレーテツド スピロ環gpr40調節因子
EP2440541A1 (en) 2009-06-09 2012-04-18 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
TW201643169A (zh) 2010-07-09 2016-12-16 艾伯維股份有限公司 作為s1p調節劑的螺-哌啶衍生物
PL2646425T3 (pl) 2010-12-01 2015-12-31 Boehringer Ingelheim Int Kwasy indanyloksydihydrobenzofuranylooctowe użyteczne do leczenia zespołu metabolicznego

Similar Documents

Publication Publication Date Title
JP2015519322A5 (enExample)
JP2009530398A5 (enExample)
JP2013508279A5 (enExample)
JP2010077141A5 (enExample)
JP2017531038A5 (enExample)
JP2013500314A5 (enExample)
JP2009535307A5 (enExample)
JP2013501008A (ja) 抗ウイルス性化合物ならびにそれを含む医薬組成物
JP2010524932A5 (enExample)
JP2013519632A5 (enExample)
JP2007523155A5 (enExample)
JP2011527334A5 (enExample)
JP2010514832A5 (enExample)
JP2009533410A5 (enExample)
JP2015523339A5 (enExample)
JP2020507589A5 (enExample)
JP2010522710A5 (enExample)
JP2019520344A5 (enExample)
JP2011046708A5 (enExample)
CN103102348B (zh) 噁二唑类化合物及其制备方法、药物组合物及其用途
JP2011526286A5 (enExample)
JP2005526773A5 (enExample)
JP2014517848A5 (enExample)
JP2010514734A5 (enExample)
JP2008530242A5 (enExample)